tiprankstipranks
Advertisement
Advertisement

DE:DX5 Stock Latest News

Daxor to showcase next-gen portable BVA at ACC.26 session
The FlyDaxor to showcase next-gen portable BVA at ACC.26 session
23d ago
DXR
Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress
PremiumThe Fly
Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress
1M ago
DXR
Daxor issues update in Letter to Shareholders
PremiumThe Fly
Daxor issues update in Letter to Shareholders
1M ago
DXR
Daxor reports NAV per share of $9.07
PremiumThe Fly
Daxor reports NAV per share of $9.07
1M ago
DXR
Daxor continues strategic expansion, opens new BVA program in Tennessee
PremiumThe Fly
Daxor continues strategic expansion, opens new BVA program in Tennessee
1M ago
DXR
Daxor initiated with a Buy at Lake Street
PremiumThe FlyDaxor initiated with a Buy at Lake Street
2M ago
DXR
Daxor to transition to Securities Exchange Act of 1934 reporting company
Premium
The Fly
Daxor to transition to Securities Exchange Act of 1934 reporting company
2M ago
DXR
Daxor Files Legal Opinion Affirming Validity of Stock
Premium
Company Announcements
Daxor Files Legal Opinion Affirming Validity of Stock
2M ago
8K
DXR
Daxor prices 765,958 shares at $11.75 in registered direct offering
PremiumThe Fly
Daxor prices 765,958 shares at $11.75 in registered direct offering
3M ago
DXR
Daxor Releases Updated Investor Presentation to Public Markets
PremiumCompany Announcements
Daxor Releases Updated Investor Presentation to Public Markets
3M ago
8K
DXR
Daxor announces expansion of its BVA platform into three new facilities
PremiumThe Fly
Daxor announces expansion of its BVA platform into three new facilities
5M ago
DXR
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference
PremiumThe Fly
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference
6M ago
DXR
Daxor debuts FDA-cleared BVA analyzer at HFSA meeting
PremiumThe FlyDaxor debuts FDA-cleared BVA analyzer at HFSA meeting
6M ago
DXR
Daxor unveils next-gen BVA analyzer at HFSA annual meeting
Premium
The Fly
Daxor unveils next-gen BVA analyzer at HFSA annual meeting
7M ago
DXR
Daxor’s blood volume analysis validated for COVID, sepsis patients
Premium
The Fly
Daxor’s blood volume analysis validated for COVID, sepsis patients
7M ago
DXR
Daxor reports increase in NAV to $7.15 per share
PremiumThe Fly
Daxor reports increase in NAV to $7.15 per share
7M ago
DXR
Daxor’s FDA Clearance and Advancements Propel Buy Rating Amidst Growth Potential
PremiumRatings
Daxor’s FDA Clearance and Advancements Propel Buy Rating Amidst Growth Potential
8M ago
DXR
Daxor Gains FDA Clearance for Blood Volume Analyzer
PremiumCompany Announcements
Daxor Gains FDA Clearance for Blood Volume Analyzer
8M ago
8K
DXR
Daxor receives FDA clearance for new BVA system
PremiumThe Fly
Daxor receives FDA clearance for new BVA system
8M ago
DXR
Daxor expands BVA technology into three new hospitals
PremiumThe FlyDaxor expands BVA technology into three new hospitals
9M ago
DXR
Daxor Approves Accounting Firm at Annual Meeting
Premium
Company Announcements
Daxor Approves Accounting Firm at Annual Meeting
9M ago
8K
DXR
Daxor announces new findings from Duke University on BVA
Premium
The Fly
Daxor announces new findings from Duke University on BVA
11M ago
DXR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >